Table 1 Pathogenic variants identified in this study.

From: Genetic spectrum of retinal dystrophies in Tunisia

Family

ID

Disease

Genotyping

Method

Size of homozygous region, in Mb

Chr

Gene

DNA pathogenic variant

Predicted protein variant

Reference sequence

Previously reported

SIFT

PolyPhen

F1

LCA

WES

14q11.2

RPGRIP1

c.[3113-3114delCT];[3113-3114delCT]

p.[T1038Rfs*8]; T1038Rfs*8]

NM_020366

This study

F2

LCA

IROme

17p31.1

GUCY2D

c.[2660 T > G];[2660 T > G]

p.[V887G];[V887G]

NM_000180

This study

and6

0

0.999

F3

LCA

Asper

1p31.3

RPE65

c.[700C > T];[700C > T]

p.[R234*];[R234*]

NM_000329

29

F4

LCA

WES

3q13.33

IQCB1

c.[994C > T];[994C > T]

p.[R332*];[R332*]

NM_001023570

30

F5

LCA

WES

1q31.3

CRB1

c.[3542 + 1G > A];[3542 + 1G > A]

NM_201253.2

This study

F6

CRD

WES

40

1q31.3

CRB1

c.[2506C > A];[2506C > A]

p.[P836T];[P836T]

NM_201253.2

31

0.04

0.999

F7

CRD

WES

124

1q31.3

CRB1

c.[ 2105A > G];[ 2105A > G]

p.[Y702C];[Y702C]

NM_201253.2

32

0

0.89

F8

CRD

WES

10q23.1

CDHR1

c.[863-2_863-1delAG];[863-2_863-1delAG]

NM_033100

This study

F9

CRD

WES

8q22.1

C8ORF37

c.[470 + 1G > T];[470 + 1G > T]

NM_177965

This study

F10

CRD

WES

2p23.2

C2ORF71

c.[2756_2768del13];[ 2756_2768del13]

p.[K919Tfs*2];[ K919Tfs*2]

NM_001029883

33

F11

CRD

WES

35

1p22.1

ABCA4

c.[1916A > G];[1916A > G]

p.[Y639C];[Y639C]

NM_000350.2

This study

0.01

1

F12

RP

WES

77

1p22.1

ABCA4

c.[4139C > T];[4139C > T]

p.[P1380L];[P1380L]

NM_000350.2

34

0

0.716

F13

STGD

WES

1p22.1

ABCA4

c.[1140 T > A];[1140 T > A]

p.[N380K];[N380K]

NM_000350.2

35

0.01

0.05

F14

STGD

WES

1p22.1

ABCA4

c.[3259G > A];[3259G > A]

p.[E1087K]; [E1087K]

NM_000350.2

36

0

0.999

F15

CRD/STGD

WES

1p22.1

ABCA4

c.[3259G > A];[3259G > A]

p.[E1087K]; [E1087K]

NM_000350.2

36

0

0.999

F16

RP

WES

1p36.22

NMNAT1

c.[37G > A];[37G > A]

p.[A13T];[A13T]

NM_001297778.1

8

0

1

F17

RP

WES

6p21.1

PRPH2

c.[133C > T];[ =]

p.[L45F];[ =]

NM_000322

37

0

0.991

F18

RP

WES

2p15

FAM161A

c.[685C > T];[685C > T]

p.[R229*];[R229*]

NM_001201543

38

F19

RP

WES

16q21

CNGB1

c.[2293C > T];[2293C > T]

p.[R765C];[R765C]

NM_001297

This study

and 6

0

0.999

F20

RP

WES

6q12

EYS

c.(1766 + 1_1767-1)_(2023 + 1_2024-1)del

NM_001292009

39

F21

RP

WES

6q12

EYS

c.[5928-2A > G];[5928-2A > G]

NM_001292009

9

F22

SBB

WES

2q31.1

BBS5

c.[214G > A];[214G > A]

p.[G72S];[G72S]

NM_152384.2

40

0

1

F23

SBB

WES

48

2q31.1

BBS5

c.[123delA];[123delA]

p.[G42Efs*11];[ G42Efs*11]

NM_152384.2

41

F24

ACHM

WES

119

2q11.2

CNGA3

c.[1114C > T];[1114C > T]

p.[P372S];[P372S]

NM_001298.2

42

0

0.989

F25

ACHM

WES

87c

8q21.3

CNGB3

c.[1810C > T];[1810C > T]

p.[R604*];[R604*]

NM_019098.4

43

F26

CSNB

WES

15q13.3

TRPM1

c.[3947 T > G];[3947 T > G]

p.[L1316R];[L1316R]

NM_002420.5

This study

0

0.075

  1. Genes highlighted in bold harbor the novel pathogenic variants identified in this study.
  2. LCA = Leber congenital amaurosis; RP = retinitis pigmentosa; CRD = cone-rod dystrophy; STGD = Stargardt disease; BBS = Bardet–Biedl syndrome; ACHM = Achromatopsia; CSNB = congenital stationary night blindness.